SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Raymond James Reiterates Strong Buy on ChemoCentryx, Raises Price Target to $102

Raymond James reiterates ChemoCentryx (NASDAQ:CCXI) with a Strong Buy and raises the price target from $38 to $102.

Benzinga · 05/12/2020 11:27

Raymond James reiterates ChemoCentryx (NASDAQ:CCXI) with a Strong Buy and raises the price target from $38 to $102.